A prospective study of androgen levels, hormone related genes and risk of rheumatoid arthritis
IntroductionRheumatoid arthritis (RA) is more characteristic in females than males and women steroid hormones may in bite diagram this difference. We conducted a case-control interpret nested within two prospective studies to clinch the associations between plasma steroid hormones measured prior to RA onslaught and polymorphisms in the androgen receptor (AR), oestrogen receptor 2 (ESR2), aromatase (CYP19) and progesterone receptor genes (PGR) and RA risk. Methods: We genotyped AR, ESR2, CYP19, PGR single nucleotide polymorphisms (SNPs) and the AR CAG repeat in RA case-control studies nested within the Nurses' Health Scan (NHS), Nurses' Health Announce II (449 RA cases, 449 controls) and the Women'
Ultrasound has the potential to detect degeneration of articular cartilage clinically, even if the information is obtained from an indirect measurement of intrinsic physical characteristics
This dispatch is the response to the charge shown by Zheng [1] regarding our article [2]. Because our ultrasound system obtains oblique cue on intrinsic physical characteristics of living human articular cartilage in vivo settings, we chew over that the expression intensity obtains info including the intrinsic physical characteristics. We do not disregard to degree the intrinsic physical characteristics. Indeed, the vocable intensity correlated with the aggregate modulus of articular cartilage significantly [3]. We mentioned the equations of Early modulus, indicating speed of sound, density of a material, and acoustic impedance of a information [4] and presented Gabor overhaul as the gargantuan wavelet and equations [2].
Degradome expression profiling in human articular cartilage
IntroductionThe molecular mechanisms underlying cartilage destruction in osteoarthritis are poorly understood. Proteolysis is a gloss naked truth in the turnover and degradation of cartilage extracellular matrix where the center of probation has been on the metzincin family of metalloproteinases. However, there is able-bodied evidence to indicate influential roles for other catalytic classes of proteases, with both extracellular and intracellular activities. The stop of this glance at was to profile the expression of the majority of protease genes in all catalytic classes in mean human cartilage and that from patients with osteoarthritis (OA) using a quantitative method.
Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study
IntroductionSince current treatment options for patients suffering from active rheumatoid arthritis (RA) latest inadequate, especially for those unresponsive to disease-modifying antirheumatic drugs (DMARDs), cutting edge and improved medication is needed. This announce evaluates the safety and efficacy of masitinib (AB1010), a potent and selective protein tyrosine kinase inhibitor of c-KIT, in the monotherapy treatment of DMARD-refractory RA. Methods: This was a multicentre, uncontrolled, open-label, randomised, dose-ranging, phase 2a trial. Masitinib was administered orally to 43 patients who had inadequate response to DMARDs, at initial randomised dosing levels of 3 and 6 mg/kg per period over a 12-week period.
Predicting the future of anti-TNF therapy
Tumor necrosis item (TNF) antagonists are approved worldwide for the treatment of rheumatoid arthritis (RA). Clinical experience revealed that TNF blocking therapy is single effective for encompassing two-thirds of patients, reflecting that there are ' responders' as blooming as ' nonresponders' . Obsessed the destructive nature of RA, the risk of adverse effects and appreciable costs for therapy, there is a firm want to produce predictions on success before the derivation of therapy. In the now puzzle of Arthritis Check & Therapy Hueber and colleagues are the beginning to present a multi-parameter serum protein biomarker fix that has predictive value prior to the start of anti-TNF treatment.
Antiphospholipid antibody profiles in lupus nephritis with glomerular microthrombosis: a prospective study of 124 cases
IntroductionGlomerular microthrombosis (GMT) is a common vascular copper in patients with lupus nephritis (LN). The mechanism underlying GMT is especially unknown. Although many studies accept reported the collection of antiphospholipid antibodies (aPL) with GMT, the consociation between GMT and aPL remains controversial. Preceding studies have demonstrated that some aPL could bind to several hemostatic and fibrinolytic proteases that plam homologous enzymatic domains. Of the protease-reactive aPL, some can inhibit the anticoagulant movement of activated protein C and the fibrinolytic avail of plasmin, and hinder the antithrombin inactivation of thrombin. The location of this scan was to investigate the prevalence of GMT in LN patients and examine the alliance between the aPL profiles (including some protease-reactive aPL) and GMT.
The utility of MRI in predicting radiographic erosions in the metatarsophalangeal joints of the rheumatoid foot: a prospective longitudinal cohort study
IntroductionMagnetic resonance imaging (MRI) may divulge rheumatoid arthritis (RA) changes in the feet when hands are normal. The bourn of this study was to determine the sensitivity, specificity, pleasant predictive bill (PPV) and negative predictive price (NPV) of a metatarsophalangeal (MTP) erosion on MRI to predict a subsequent radiographic erosion in the same joint. Corresponding analyzes were performed for bone marrow oedema predicting a subsequent MRI erosion. Descriptive results of other lesions are reported. Methods: Fifty patients with RA of less than 5 years duration who were rheumatoid factor (RF) positive and/or anti-CCP assured were recruited.
Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study
IntroductionAggrecanase cleavage at the 392Glu-393Ala bond in the interglobular domain (IGD) of aggrecan, releasing N-terminal 393ARGS fragments, is an early key reality in arthritis and seam injuries. Here we capitalization a quantitative immunoassay of aggrecan ARGS neoepitope fragments in human synovial fluid to determine if this cleavage-site particular form better identifies joint pathology than formerly available less specific aggrecan assays.MethodSynovial fluid (SF) from 26 knee healthy humans (reference) and 269 patients were analysed in a cross-sectional study. Patient groups were acute inflammatory arthritis, acute knee injury, chronic knee injury and knee osteoarthritis (OA).
Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus
IntroductionAutoantibodies against C1q correlate with lupus nephritis. We compared titers of anti-C1q and anti-dsDNA in 70 systemic lupus erythematosus (SLE) patients with (n=15) or without (n=55) subsequent biopsy-proven lupus nephritis. Methods: The 15 patients with subsequent lupus nephritis had anti-C1q assays during clinical flares (mean SLEDAI, 10.0+/-4.7; range, 3 to 22) before the diagnosis of lupus nephritis (median, 24 months; compass 3 to 192). Among the 55 others, 33 patients had active lupus (mean SLEDAI, 10.3+/-6.2; range, 4 to 30) without renal disease during follow-up (median 13 years; scope 2 to 17 years) and 22 had inactive lupus (mean SLEDAI: 0;
Gout. Imaging of gout: findings and utility
Imaging is a benevolent stuff for clinicians to evaluate diseases that induce chronic joint inflammation. Chronic gout is associated with changes in joint structures that may be evaluated with miscellaneous imaging techniques. Plain radiographs exposition universal changes solitary in contemporary chronic gout. Computed tomography may capital evaluate bone changes, whereas attractive resonance imaging is suitable to evaluate soft tissues, synovial membrane thickness, and inflammatory changes. Ultrasonography is a effects that may be used in the clinical setting, allowing test of cartilage, soft tissues, urate crystal deposition, and synovial membrane inflammation.
